Conmed (CNMD) Total Current Liabilities (2010 - 2026)

Conmed's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $292.7 million for Q1 2026.

• Quarterly Total Current Liabilities rose 3.38% year-over-year to $292.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $292.7 million (up 3.38% YoY) and the FY2025 annual result came in at $315.0 million, up 13.27% from the prior year.
• Total Current Liabilities was $292.7 million for Q1 2026 at Conmed, down from $315.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $376.3 million in Q3 2023 and bottomed at $187.6 million in Q1 2022.
• A 5-year average of $286.7 million and a median of $292.7 million in 2026 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Current Liabilities soared 80.42% — and 2024, when it dropped 24.98%.
• Conmed's Total Current Liabilities stood at $296.6 million in 2022, then climbed by 4.78% to $310.7 million in 2023, then retreated by 10.49% to $278.1 million in 2024, then grew by 13.27% to $315.0 million in 2025, then retreated by 7.09% to $292.7 million in 2026.
• Business Quant data shows CNMD's Total Current Liabilities at $292.7 million in Q1 2026, $315.0 million in Q4 2025, and $314.7 million in Q3 2025.